Gault L, Ritchie CW, Robieson WZ, Pritchett Y, Othman AA, Lenza RA. A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia. Alzheimers Dement: Trans Res Clin Interv. 2015 Jun;1(1):81–90.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Nelonicline